IL10 and diabetes mellitus: Accumulating evidence suggests roles for NOD-like receptor family pyrin domain containing 3 (NLRP3) in mediating inflammation and interleukin-10 (IL-10) in mediating anti-inflammatory effects in diabetes and cardiovascular diseases (Groslambert and Py, 2018).